RADIANCE-HTN TRIO

Published: May 21, 2021, 5:58 p.m.

Dr. Ajay Kirtane, of Columbia University Vagelos College of Physicians and Surgeons and New York-Presbyterian/Columbia University Irving Medical Center, discusses the RADIANCE-HTN TRIO trial with Dr. Waksman. The study, presented as a late-breaking trial at ACC.21 Virtual, showed that ultrasound renal denervation, as compared with a sham procedure, reduced blood pressure at 2 months in patients with hypertension resistant to a standardized triple-combination pill.